![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia radiactiva en estudio para el diagnóstico del cáncer. La fluorotimidina F 18 se inyecta en la sangre del paciente y despide radiación mientras se descompone. Esta ayuda a lograr imágenes claras de los tumores durante la exploración con tomografía por emisión de positrones (exploración con TEC). Es un tipo de radiofármaco. |
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081024154417im_/http://www.nci.nih.gov/images/spacer.gif) |